9月18日，因生产的宠物饲料未按规定进行产品质量检验，邢台市农业农村局对河北够派宠物食品有限 责任公司处以1.5万元罚款。 据调查，该公司2025年1月1日至5月28日期间生产的包括益生菌猫粮、鱼油猫粮等品类，共计584袋的10 批次添加冻干小包装宠物饲料未进行产品质量检验。 执法人员调取企业生产记录和自检数据发现，上述产品生产日期集中于2025年2月至5月。虽然该公司对 同期的200批次宠物配合颗粒饲料进行了检测，但根据国家标准GB/T31216-2014和GB/T31217-2014规 定，添加冻干物质后的产品因材料变更需重新认定批次并实施出厂检验。 立案后，执法人员于6月10日约谈负责销售的电商公司法人及化验员，并向企业送达《责令改正通知 书》。7月8日复查确认，该公司自5月29日起生产的每批次产品均已落实自检要求。 依据《饲料和饲料添加剂管理条例》第四十条及河北省裁量基准，监管部门认定企业行为违反《宠物饲 料管理办法》第六条，但因"及时改正"适用较轻处罚幅度，最终处罚款1.5万元。 有消费者曾投诉称 对于此次行政处罚，南都·湾财社记者通过天眼查所提供的联系方式对河北够派宠物食品有限责任公司 进行了多次 ...

Core Viewpoint - Shandong Meiqiqi Biotechnology Co., Ltd. was fined a total of 28,140 yuan for producing counterfeit veterinary drugs and pet feed without a production license [1][6][20] Company Summary - Shandong Meiqiqi Biotechnology Co., Ltd. was found to have produced six types of products labeled with therapeutic claims for pet diseases, without obtaining the necessary veterinary drug production license [2][4] - The company was established in 2015 and focuses on the research, production, and marketing of pet functional nutrition products, primarily oral liquids for pets [7] - Despite the administrative penalties, the company's website still contains links to dog food products, although specific product details are currently inaccessible [7][9] Regulatory Summary - The administrative penalties were based on violations of the Veterinary Drug Management Regulations and the Pet Feed Management Measures, resulting in the confiscation of illegal goods and a fine [6][19] - The company produced 40 bags of dog food without the required pet feed production license, with a total value of 2,400 yuan [4][6] - The regulatory environment is tightening, with the Ministry of Agriculture and Rural Affairs launching a special rectification action plan to address illegal veterinary drug operations, particularly online [17][19] Industry Summary - The pet medical market is the second largest segment within the pet industry, accounting for 28% of the market share, with a projected growth in the pet medical market from 150 billion yuan in 2019 to 500 billion yuan by 2025, reflecting a compound annual growth rate of 20% [15][16] - The market structure includes pet hospitals, pet drugs, and pet health care, with pet hospitals holding the largest market share [16] - The rapid growth of the pet market has exposed regulatory gaps and quality safety issues, necessitating improved management and oversight [16]